ABBV
Abbvie Inc
Price:  
166.42 
USD
Volume:  
5,175,121.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Abbvie EV/EBITDA

32.1%
Upside

As of 2024-05-18, the EV/EBITDA ratio of Abbvie Inc (ABBV) is 12.07. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Abbvie's latest enterprise value is 350,605.56 mil USD. Abbvie's TTM EBITDA according to its financial statements is 29,042.00 mil USD. Dividing these 2 quantities gives us the above Abbvie EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 15.5x - 24.9x 20.2x
Forward P/E multiples 24.8x - 38.2x 30.9x
Fair Price 106.17 - 376.16 219.82
Upside -36.2% - 126.0% 32.1%
166.42 USD
Stock Price
219.82 USD
Fair Price

Abbvie EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-05-17 12.07
2024-05-16 11.95
2024-05-15 11.91
2024-05-14 11.78
2024-05-13 11.76
2024-05-10 11.73
2024-05-09 11.71
2024-05-08 11.71
2024-05-07 11.84
2024-05-06 11.85
2024-05-03 11.91
2024-05-02 11.73
2024-05-01 11.79
2024-04-30 11.84
2024-04-29 11.77
2024-04-26 11.66
2024-04-25 12.13
2024-04-24 12.16
2024-04-23 12.26
2024-04-22 12.16
2024-04-19 12.07
2024-04-18 11.97
2024-04-17 11.94
2024-04-16 11.84
2024-04-15 11.78
2024-04-12 11.82
2024-04-11 12.14
2024-04-10 12.23
2024-04-09 12.30
2024-04-08 12.28
2024-04-05 12.29
2024-04-04 12.16
2024-04-03 12.74
2024-04-02 12.94
2024-04-01 12.95
2024-03-28 13.03
2024-03-27 12.92
2024-03-26 12.85
2024-03-25 12.81
2024-03-22 12.81
2024-03-21 12.75
2024-03-20 12.67
2024-03-19 12.88
2024-03-18 12.81
2024-03-15 12.77
2024-03-14 12.97
2024-03-13 12.89
2024-03-12 12.96
2024-03-11 12.88
2024-03-08 12.83